• Home
  • About Journal
    Journal Introduction
    Editorial Board
    Youth Editorial Board
    Cooperating Institutions
    Editorial Department
  • Submission Guidelines
  • Policies & Statements
    Ethical Guidelines for Publication
    Academic Misconduct Statement
    Open Access (OA) Statement
    AIGC Use Statement
  • Journal Subscription
  • Download Center
  • 中文版
Cite this article:
GENG Xue,WANG Xue,ZHOU Qian,SU Xinyu,LI Shuixian,ZHU Qingfen.Inhibitory effect of baicalin on SARS-COV-2 invasion[J].Journal Of Pharmaceutical Research,2024,43(4):333-337[Click to copy]
【Print this page】      【Download PDF Full Text】   【View/Add Comment】  【Download reader】  【 Close 】
←Previous|Next→ Archive    Advanced Search
This article has been viewed: 2756times   Download 2636次 QR Code for this article
Scan with your phone!
黄芩苷对SARS-CoV-2侵袭的抑制作用研究
耿雪1,2,王雪1,周倩3,苏昕宇1,李水仙1,祝清芬1
Font:Larger+|Default|Smaller-
(1.山东省食品药品检验研究院,国家药品监督管理局胶类产品质量评价重点实验室,中药标准创新与质量评价工程实验室,山东 济南 250101;2.山东中医药大学,山东 济南 250355;3.山东省中医药研究院,山东 济南 250014)
摘要:
目的 在体外研究黄芩苷对新型冠状病毒(2019-nCoV)入侵细胞过程的抑制作用。方法 利用构建有荧光素酶报告基因的SARS-CoV-2 S蛋白假病毒系统,通过荧光素酶试剂盒检测加入黄芩苷和假病毒后Huh-7细胞中的荧光素表达变化,进而绘制病毒抑制曲线。结果 黄芩苷能显著抑制Huh-7细胞的病毒感染率,黄芩苷和病毒提前共孵育组与直接加入组在不同浓度下的病毒抑制曲线并无显著差别,表明黄芩苷并不能与病毒直接结合,而是通过作用于病毒S蛋白介导的细胞融合过程产生抑制作用;黄芩苷在0.125 mg•mL-1浓度时,对病毒的抑制率在4 h组显著降低,在0 h和2 h组并无显著差别,表明黄芩苷可能在病毒入侵细胞(非吸附)阶段产生抑制作用,且介导的入侵抑制阶段发生在4 h内。结论 黄芩苷可能通过介导抑制SARS-CoV-2病毒S蛋白与细胞表面受体的融合过程,在非吸附阶段抑制病毒的入侵,发挥抗新冠病毒活性。
关键词:  黄芩苷  新型冠状病毒  荧光素酶检测  SARS-CoV-2 S蛋白
DOI:10.13506/j.cnki.jpr.2024.04.004
基金项目:山东省自然科学基金重点项目(No.ZR2020KH021);山东省食品药品检验研究院院级课题(No.SDIFDC-KY-2021009)
Publication Date:April 25, 2024
Inhibitory effect of baicalin on SARS-COV-2 invasion
GENG Xue1,2,WANG Xue1,ZHOU Qian3,SU Xinyu1,LI Shuixian1,ZHU Qingfen1
(1. Laboratory for Standard Innovation and Quality Evaluation of TCM, NMPA Key Laboratory for Quality Evaluation of Gelatin Products, Shandong Institute for Food and Drug Control, Jinan 250101, China;2. Shandong University of Traditional Chinese Medicine, Jinan 250355, China;3. Shandong Academy of Chinese Medicine, Jinan 250014, China)
Abstract:
Objective To study the antiviral efficacy of baicalin on SARS-COV-2 entry process in vitro. Methods The SARS-CoV-2 S pseudo-typed virions containing a luciferase reporter gene and Luciferase kit were used to detect the changes of fluorescein expression caused by baicalin in Huh-7 cells after incubation with the pseudo typed virion, and then the virus inhibition curve is plotted. Results Baicalin can significantly inhibited the infection rate of pseudo virus. There was no significant difference in the virus inhibition curve between the baicalin & virus pre-incubation group and co-incubation at different concentrations, indicating that baicalin could not directly bind to virus, but could play an antiviral role by affecting the cell fusion process mediated by the virus S protein. We further found that, the inhibition rate of baicalin to virus decreased significantly in the 4h group, but had no significant difference in the 0 h and 2 h groups at the concentration of 0.125 mg•mL-1, indicating that baicalin may have an inhibitory effect on virus invasion stage rather than adsorption stage, and the mediated inhibition stage occurred within 4 h. Conclusion Baicalin may mediate the fusion of SARS-CoV-2 S protein with cell surface receptor and exert anti-SARS-CoV-2 activity by playing a role in inhibiting virus invasion in non-adsorption stage.
Key words:  Baicalin  SARS-CoV-2  Luciferase assay  SARS-CoV-2 protein
Today's Visits:511    Total Visits:2383242
Website copyright:Editorial Board of Journal of Pharmaceutical Research     鲁ICP备17018036号-3     鲁公网安备 37010202001351号
Sponsored by:Shandong Institute for Food and Drug Control Shandong Pharmaceutical Association Address:No.2749 Xinluo Street,High-Tech Zone,Jinan,P.R.China Postcode:250101
Telephone Number:0531-81216586 Email :yaoxueyanjiu@163.com;yaoxueyanjiu@126.com
Technical Support:Beijing Qinyun Technology Co., Ltd.